Pharming (PHAR) Current Assets (2019 - 2026)

Pharming (PHAR) has 8 years of Current Assets data on file, last reported at $280.7 million in Q2 2026.

• Quarterly Current Assets rose 14.21% year-over-year to $280.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $280.7 million (up 14.21% YoY) and the FY2025 annual result came in at $299.5 million, up 7.55% from the prior year.
• Current Assets slipped to $280.7 million in Q2 2026, from $295.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $316.3 million in Q4 2023 to a low of $252048.0 in Q3 2022.
• A 5-year average of $260.0 million and a median of $278.0 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets plunged 99.9% — and 2023, when it jumped 115646.6%.
• Tracing PHAR's Current Assets over 5 years: stood at $277.5 million in 2022, then climbed by 14.0% to $316.3 million in 2023, then decreased by 11.98% to $278.4 million in 2024, then rose by 7.55% to $299.5 million in 2025, then retreated by 6.27% to $280.7 million in 2026.
• The last three Current Assets figures came in at $280.7 million (Q2 2026), $295.5 million (Q1 2026), and $299.5 million (Q4 2025), per Business Quant data.